InsidersTradesSigma
Total declarations
Company
▲ Purchases (15 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
15
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-33.9%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by POWERS JOHNNY D, Director. Insider active across 1 company, notably Zomedica Corp.. Aggregated, 19 filings have been recorded. Split: 15 buys · 0 sell. Total volume traded: €364k. Activity tracked since 17 May 2021. The latest transaction was filed on 19 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations19 total
500,000 shares@ US$0.0464.4% of flowCommon Stock, without par valueSEC:0001654954-25-005943:0
Ideal exit: 13 Feb 2026 (T+270)
100,000 shares@ US$0.0691.3% of flowCommon Stock, without par valueSEC:0001654954-25-002963:0
Ideal exit: 12 Dec 2025 (T+270)
100,000 shares@ US$0.1212.4% of flowCommon Stock, without par valueSEC:0001654954-24-014107:0
Ideal exit: 8 Aug 2025 (T+270)
100,000 shares@ US$0.1292.5% of flowCommon Stock, without par valueSEC:0001654954-24-011206:0
Ideal exit: 25 May 2025 (T+270)
50,000 shares@ US$0.1791.7% of flowCommon Stock, without par valueSEC:0001654954-24-006605:0
Ideal exit: 11 Feb 2025 (T+270)
25,000 shares@ US$0.1840.9% of flowCommon Stock, without par valueSEC:0001654954-24-006580:0
Ideal exit: 10 Feb 2025 (T+270)
19,406 shares@ US$0.1390.5% of flowCommon Stock, without par valueSEC:0001654954-24-006413:0
Ideal exit: 8 Feb 2025 (T+270)
100,000 shares@ US$0.142.8% of flowCommon Stock, without par valueSEC:0001654954-24-006245:0
Ideal exit: 7 Feb 2025 (T+270)
100,000 shares@ US$0.1653.2% of flowCommon Stock, without par valueSEC:0001654954-23-015673:0
Ideal exit: 10 Sept 2024 (T+270)
100,000 shares@ US$0.1653.2% of flowCommon Stock, without par valueSEC:0001654954-23-015665:0
Ideal exit: 10 Sept 2024 (T+270)
100,000 shares@ US$0.1663.2% of flowCommon Stock, without par valueSEC:0001654954-23-014622:0
Ideal exit: 13 Aug 2024 (T+270)
150,000 shares@ US$0.1735.1% of flowCommon Stock, without par valueSEC:0001654954-23-014492:0
Ideal exit: 11 Aug 2024 (T+270)
100,000 shares@ US$0.19343.8% of flowCommon Stock, without par valueSEC:0001654954-23-007247:0
Ideal exit: 19 Feb 2024 (T+270)
250,000 shares@ US$0.450.099% mcap32.5% of flowCommon Stock, without par valueSEC:0001654954-21-012518:0
Ideal exit: 15 Aug 2022 (T+270)
250,000 shares@ US$0.4565.0% of flowCommon Stock, without par valueSEC:0001654954-21-012518
Ideal exit: 15 Aug 2022 (T+270)
125,000 shares@ US$0.265.7% of flowCommon Stock, without par valueSEC:0001171843-21-004365
125,000 shares@ US$0.260.027% mcap8.8% of flowCommon Stock, without par valueSEC:0001171843-21-004365:0
125,000 shares@ US$0.260.027% mcap8.7% of flowCommon Stock, without par valueSEC:0001171843-21-003571:0
125,000 shares@ US$0.268.7% of flowCommon Stock, without par valueSEC:0001171843-21-003571
19 of 19 declarations
About POWERS JOHNNY D
Johnny D. Powers is a Board Member at Zomedica Corp. He has experience in the veterinary sector and contributes to the company's strategy. As a Board Member, he plays a key role in governance and strategic decision-making that influences Zomedica's future.
